Cancers

Latest research

1. Fused in Sarcoma (FUS) promotes renal cell carcinoma progression via the KCMF1/FUS/CENPT axis and activation of the JNK signaling pathway

   • Zaiqing Jiang
   • Rui Zhang
   • Zongliang Zhang

   in Journal of Translational Medicine

   Article Open access 03 November 2025

   

2. Camrelizumab plus chemotherapy versus chemoradiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma: Phase 2 randomized trial (REVO)

   • Peiyuan Wang
   • Yujie Chen
   • Jiancheng Li

   in Nature Communications

   Article Open access 03 November 2025

   

3. RNA sequencing reveals novel lncRNA modulators in gemini nanocurcumin–treated colorectal cancer cells

   • Zohre Zibaei
   • Hewa Jalal Azeez
   • Esmaeil Babaei

   in Scientific Reports

   Article Open access 03 November 2025

   

4. EHBMT, a method for visualizing tumor evolution, identifies a surge in gastric cancer with hybrid epithelial–mesenchymal phenotypes due to an inflammatory microenvironment

   • Dandan Li
   • Zeng Zhou
   • Shanshan Qin

   in Experimental & Molecular Medicine

   Article Open access 03 November 2025

   

5. Differential effects of KRAS G-domain and hypervariable region mutants on cancer phenotypes

   • James Allen D. de Borja
   • Kim Denyse J. Hao Lin
   • Reynaldo L. Garcia

   in Scientific Reports

   Article Open access 03 November 2025

   

6. FAM3B overexpression correlates with poor prognosis and immune dysregulation in colorectal cancer: insights from bioinformatics and Mendelian randomization analyses

   • Peng Huang
   • Pei Li
   • Jialin Zhang

   in Discover Oncology

   Article Open access 03 November 2025

   

7. Predicting Tumor Regrowth in Patients Undergoing Non-Operative Management after Total Neoadjuvant Therapy

   • Kamil Erozkan
   • Emily Simon
   • Ronald Charles

   in Journal of Gastrointestinal Cancer

   Article Open access 03 November 2025

   

8. Clinical relevance of perioperative changes in circulating tumor cells in resectable colorectal cancer

   • Qiang Feng
   • Chen Ni
   • Dan Wu

   in BMC Cancer

   Article Open access 03 November 2025

   

9. ASCO 2025: metastatic colorectal cancer—focus on precision oncology

   • Renate Schaberl-Moser

   in memo - Magazine of European Medical Oncology

   Article Open access 03 November 2025

10. Prognostic value of MYBL2 and its potential implications for immunotherapy: a study of bioinformatics and experimental validation

    • Jingyuan Pei
    • Jianhui Fan
    • Gang Wang

    in British Journal of Cancer

    Article 03 November 2025

    

11. Differential prognostic significance of tumor size and node in invasive lobular carcinoma of breast

    • Eunhye Kang
    • Ik Beom Shin
    • Hyeong-Gon Moon

    in Breast Cancer Research

    Article Open access 03 November 2025

    

12. Neoadjuvant Therapy for Invasive Intraductal Papillary Mucinous Neoplasms: A Comparative Study With Pancreatic Ductal Adenocarcinoma

    • Hiroyuki Ishida
    • Salvador Rodriguez Franco
    • Marco Del Chiaro

    in Annals of Surgical Oncology

    Article 03 November 2025

    

13. Fragile X mental retardation 1 gene FMR1 promotes proliferation, migration, and invasion of gastric cancer cells via c-MYC

    • Yiqian Han
    • Chenxi Mao
    • Fenglei Wu

    in Journal of Translational Medicine

    Article Open access 03 November 2025

    

14. The Hippo-YAP signaling pathway promotes hepatocellular carcinoma progression by inducing FHL3 expression

    • Dean Rao
    • Tiantian Wang
    • Limin Xia

    in Cell Death & Disease

    Article Open access 03 November 2025

    

15. Functional dominance in the central dogma of tumor mitochondrial genetics

    in Nature Genetics

    Article 03 November 2025

    

16. Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial

    • Mouhamad Khouja
    • Elisa Genuardi
    • Maria Gomes da Silva

    in Leukemia

    Article Open access 03 November 2025

    

17. Clinicopathological Correlation of Hormone Receptors, Angiogenesis, and Tumor Budding in Endometrial Carcinoma: A Tertiary Care Center Study

    • Senjuti Dasgupta
    • Arpita Das
    • Ujjwal Bandyopadhyay

    in The Journal of Obstetrics and Gynecology of India

    Article 03 November 2025

    

18. The impact of tislelizumab immunotherapy on multiple primary lung cancer presenting as ground-glass nodules: preliminary results analysis from a single-arm, phase II trial

    • Junfei Wu
    • Xiangning Fu
    • Yixin Cai

    in Cancer Immunology, Immunotherapy

    Article Open access 03 November 2025

    

19. MS4A1 regulates M1-polarized tumor-associated macrophage infiltration, angiogenesis, and cancer progression through the HIPPO pathway in lung adenocarcinoma

    • Weitong Gao
    • Ruqiong Wang
    • Dehai Che

    in Cancer Immunology, Immunotherapy

    Article Open access 03 November 2025

    

20. Investigation of 6-thioguanine as a strategy to overcome methotrexate resistance in a mouse model of leptomeningeal carcinomatosis

    • Hidemitsu Nakagawa
    • Yoshihiro Yui
    • Masashi Kawaichi

    in Journal of Neuro-Oncology

    Article Open access 03 November 2025

    

Related journals

• 

  Journal

  BMC Cancer

  BMC Canceris an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology,...

  Publishing model

  Open Access

  Journal Impact Factor

  3.4 (2024)

  Downloads

  11,210,121 (2024)

  Submission to first decision(median)

  10 days

• 

  Journal

  Breast Cancer Research and Treatment

  Breast Cancer Research and Treatmentis an international arena for the discussion and resolution of ongoing controversies in breast cancer treatment,...

  Publishing model

  Hybrid

  Journal Impact Factor

  3.0 (2024)

  Downloads

  2,006,180 (2024)

  Submission to first decision(median)

  8 days

• 

  Journal

  British Journal of Cancer

  The British Journal of Canceris one of the most-cited general cancer journals, publishing significant advances in translational and clinical cancer...

  Publishing model

  Hybrid

  Journal Impact Factor

  6.8 (2024)

  Downloads

  7,174,039 (2024)

  Submission to first decision(median)

  6 days